TransMedics ROE - Return on Equity 2019-2024 | TMDX
- TransMedics average return on equity for 2023 was -16.9, a 69.01% decline from 2022.
- TransMedics average return on equity for 2022 was -54.54, a 45.21% decline from 2021.
- TransMedics average return on equity for 2021 was -37.56, a 14.64% increase from 2020.
Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.